ulixacaltamide
ulixacaltamide: 1 clinical trial tracked.
ulixacaltamide evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about ulixacaltamide, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
Phase 3, Decentralized, Randomized, Double-Blind, Placebo Controlled, Parallel Design, Randomized Withdrawal, and Long-term Safety Study to Evaluate the Efficacy and Safety of Ulixacaltamide (PRAX-944) in Adults With Essential Tremor
Primary endpoint: Parallel Design: Change from Baseline (CFB) to Week 8 (Day 56) on mADL11 score
InterventionalRandomizedtriple1,000 targetStarted 2023-11Completion 2027-031 site · United StatesPraxis Precision Medicines